Sign in
4

Changes in Ownership

BioCorRx Inc. Filed Acc 0001477932-16-010952

Options or other derivatives

  • President and CEO acquired 10,600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Granier Brady James President and CEO 2016-06-17 Grant or award · Stock Option +10,600,000 15,600,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…